/Companies

Catena Biosciences

YC S21

Berkeley, US · Founded 2020 · 7 employees · 23 known investors

Find your way into Catena Biosciences

Sign up to see every warm intro you have to Catena Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Catena Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells. The company partners with pharmaceutical firms to advance development of novel therapeutic modalities.

BiotechDeep TechHealthtechMedical DevicesTherapeuticsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S21)

Catena Biosciences was founded in 2020 by Marco Lobba and Matthew Francis.

MLMarco Lobba
Marco LobbaCo-Founder/CEOHe holds a Ph.D. from UC Berkeley, where his doctoral research spanned the labs of Matt Francis and Jennifer Doudna.
MF
Matthew FrancisFounder
GG
Geo Guillen

Investors · 23

Iaso Ventureslisted by Iaso VenturesCambridge

How we know: a partner's Signal profile · Y Combinator's founder network · Not right? Tell us

AJGreported

How we know: Y Combinator's founder network · Not right? Tell us

Amgen VenturesreportedThousand Oaks · $1M – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Axial VCreportedSan Francisco · $100K – $5M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

BrightEdgereportedAtlanta

How we know: Y Combinator's founder network · Not right? Tell us

CAL InnovationreportedMill Valley

How we know: Y Combinator's founder network · Not right? Tell us

NYBC VenturesreportedNew York

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Reinforced VenturesreportedPittsburgh

How we know: Y Combinator's founder network · Not right? Tell us

Social Impact CapitalreportedNew York · $100K – $1.5M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

StoryHousereportedSisters

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 2

BrightEdge - American Cancer SocietyFreeflow Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Legal entities · 1

corporate structure
Catena Biosciences, Inc.

Frequently asked questions

What does Catena Biosciences do?
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells. The company partners with pharmaceutical firms to advance development of novel therapeutic modalities.
Who founded Catena Biosciences?
Catena Biosciences was founded by Marco Lobba, Matthew Francis in 2020.
Who are Catena Biosciences's investors?
Catena Biosciences's investors include California Innovation Fund, Civilization Ventures Management, Llc, Creative Destruction Lab (CDL), FREEFLOW, Gaingels, Iaso Ventures, Jude Gomila, LongeVC and 13 more.
Where is Catena Biosciences headquartered?
Catena Biosciences is headquartered in Berkeley, US.